Boryung Pharmaceutical Co., Ltd

This study tests whether switching from one diabetes medication (DPP-4 inhibitor) to another (TZD) can better control blood sugar in people with type 2 diabetes who are already taking metformin and an SGLT2 inhibitor. About 204 adults will be randomly assigned to either stay on t…

This study tests different ways to start taking olanzapine, a common schizophrenia medication, to see if a slower dose increase can reduce side effects while still controlling symptoms. About 120 adults with schizophrenia will receive one of several dosing schedules or a placebo.…

This large observational study will follow 20,000 adults with essential hypertension who are prescribed one of two combination pills containing fimasartan. The main goal is to see how well these pills control blood pressure over 12 weeks, and a longer follow-up of up to 2 years w…

This study is testing a fixed-dose combination of two cholesterol-lowering drugs, pitavastatin and ezetimibe, in over 8,600 people with high cholesterol or mixed lipid disorders. The goal is to see how well the combo works and how safe it is in real-world conditions, outside of a…

This study watches 3,000 people with bipolar disorder who are taking olanzapine. Researchers want to see how the drug is used and if teaching patients about weight gain can help prevent it. No new treatment is given; it only collects information from regular care.

This study observes 1000 patients with metastatic colorectal cancer whose first chemotherapy stopped working. Researchers will track which second-line treatments doctors choose and how long patients live or stay cancer-free. The goal is to understand real-world treatment patterns…

This study is tracking 300 people with advanced small cell lung cancer who are taking the drug Zepzelca (lurbinectedin) after their first chemotherapy stopped working. Researchers want to see how well the drug shrinks tumors and what side effects occur in everyday hospital settin…

This study will follow 9,000 people with type 2 diabetes and high blood pressure who are already taking dapagliflozin. Researchers want to see how well the drug controls blood sugar and blood pressure in real-life settings. It is an observational study, meaning no new treatment i…

This study observes over 1,000 breast cancer patients receiving a special version of the chemotherapy drug docetaxel that contains no ethanol (alcohol). The goal is to see how often patients experience alcohol-like symptoms such as flushing or dizziness during or shortly after tr…